These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3099975)

  • 1. Selective lesioning of forebrain noradrenaline neurons at birth abolishes the improved maze learning performance induced by rearing in complex environment.
    Mohammed AK; Jonsson G; Archer T
    Brain Res; 1986 Nov; 398(1):6-10. PubMed ID: 3099975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forebrain norepinephrine and neurobehavioral plasticity: neonatal 6-hydroxydopamine eliminates enriched-impoverished experience effects on maze performance.
    Pappas BA; Saari M; Smythe J; Murtha S; Stange K; Ings R
    Pharmacol Biochem Behav; 1987 May; 27(1):153-8. PubMed ID: 3112808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal 6-hydroxydopamine alters the behavior of enriched-impoverished rats in a novel test environment.
    Saari MJ; Armstrong JN; Nobrega JN; Pappas BA; Coscina DV
    Behav Neurosci; 1990 Jun; 104(3):430-7. PubMed ID: 2112942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal 6-hydroxydopamine attenuates the neural and behavioral effects of enriched rearing in the rat.
    O'Shea L; Saari M; Pappas BA; Ings R; Stange K
    Eur J Pharmacol; 1983 Aug; 92(1-2):43-7. PubMed ID: 6414825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment.
    Luthman J; Fredriksson A; Lewander T; Jonsson G; Archer T
    Psychopharmacology (Berl); 1989; 99(4):550-7. PubMed ID: 2594922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal and adult forebrain norepinephrine depletion and the behavioral and cortical thickening effects of enriched/impoverished environment.
    Murtha S; Pappas BA; Raman S
    Behav Brain Res; 1990 Aug; 39(3):249-61. PubMed ID: 2244971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
    Carter CJ; Pycock CJ
    Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.
    Archer T; Fredriksson A; Jonsson G; Lewander T; Mohammed AK; Ross SB; Söderberg U
    Psychopharmacology (Berl); 1986; 88(2):141-6. PubMed ID: 3081924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny.
    Sachs C; Jonsson G
    Brain Res; 1975 Dec; 99(2):277-91. PubMed ID: 1182547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal brain dopamine depletion and the cortical and behavioral consequences of enriched postweaning environment.
    Pappas BA; Murtha SJ; Park GA; Condon KT; Szirtes RM; Laventure SI; Ally A
    Pharmacol Biochem Behav; 1992 Aug; 42(4):741-8. PubMed ID: 1513856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional changes induced by neonatal cerebral 6-hydroxydopamine treatment: effects of dose levels on behavioral parameters.
    Luthman J; Bassen M; Fredriksson A; Archer T
    Behav Brain Res; 1997 Jan; 82(2):213-21. PubMed ID: 9030403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamines and serotonin in rat frontal cortex after PCPA and 6-OHDA: absolute amounts and ratios.
    Reader TA
    Brain Res Bull; 1982 May; 8(5):527-34. PubMed ID: 6214300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of noradrenergic innervation compensates for behavioral deficits induced by lesion of dopaminergic terminals in the lateral septum.
    Taghzouti K; Le Moal M; Simon H
    Brain Res; 1991 Jun; 552(1):124-8. PubMed ID: 1717110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of noradrenergic and dopaminergic nerves in the rat kidney: evidence against significant dopaminergic innervation.
    McGrath BP; Lim AE; Bode K; Willis GL; Smith GC
    Clin Exp Pharmacol Physiol; 1983; 10(5):543-53. PubMed ID: 6416723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral peri-substantia nigra catecholaminergic lesion and amygdala kindling.
    Albala BJ; Moshé SL; Cubells JF; Sharpless NS; Makman MH
    Brain Res; 1986 Apr; 370(2):388-92. PubMed ID: 3085869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence that noradrenaline is not involved in the anti-immobility activity of chronic desipramine in the rat.
    Esposito E; Ossowska G; Samanin R
    Eur J Pharmacol; 1987 Apr; 136(3):429-32. PubMed ID: 3111866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
    Erinoff L; MacPhail RC; Heller A; Seiden LS
    Brain Res; 1979 Mar; 164():195-205. PubMed ID: 427556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine depletion of the diagonal band reduces baroreflex inhibition of supraoptic neurons.
    Cunningham JT; Nissen R; Renaud LP
    Am J Physiol; 1992 Aug; 263(2 Pt 2):R363-7. PubMed ID: 1510175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.